AFM13-NK Cell Therapy Success
This is a news story, published by ScienceDaily, that relates primarily to Hodgkin lymphoma news.
Hodgkin lymphoma news
For more Hodgkin lymphoma news, you can click here:
more Hodgkin lymphoma newsbiology news
For more biology news, you can click here:
more biology newsScienceDaily news
For more news from ScienceDaily, you can click here:
more news from ScienceDailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
CD16A bispecific antibody. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest AFM13 bispecific antibody news, bispecific antibody news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
NK cell treatmentScienceDaily
•Science
Science
NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma
80% Informative
NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma Phase I trial demonstrates AFM13-NK cells are safe and highly effective in heavily pretreated patients.
Pre-complexed NK cells are more readily able to find and eliminate CD30-positive lymphoma cells.
"Our trial showed the favorable safety profile and encouraging activity of AFM13-NK cells in patients with heavily pretreated refractory CD30-positive Hodgkin lymphoma ," Nieto said.
"This approach, involving cytokine-induced memory cord blood-derived NK cells, holds promise for the treatment," he said.
VR Score
91
Informative language
98
Neutral language
59
Article tone
formal
Language
English
Language complexity
62
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links
Small business owner?